BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25728347)

  • 21. Flow-dependent regulation of angiopoietin-2.
    Goettsch W; Gryczka C; Korff T; Ernst E; Goettsch C; Seebach J; Schnittler HJ; Augustin HG; Morawietz H
    J Cell Physiol; 2008 Feb; 214(2):491-503. PubMed ID: 17960565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Losartan metabolite EXP3179 activates Akt and endothelial nitric oxide synthase via vascular endothelial growth factor receptor-2 in endothelial cells: angiotensin II type 1 receptor-independent effects of EXP3179.
    Watanabe T; Suzuki J; Yamawaki H; Sharma VK; Sheu SS; Berk BC
    Circulation; 2005 Sep; 112(12):1798-805. PubMed ID: 16172287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation of tyrosine 801 of vascular endothelial growth factor receptor-2 is necessary for Akt-dependent endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells.
    Blanes MG; Oubaha M; Rautureau Y; Gratton JP
    J Biol Chem; 2007 Apr; 282(14):10660-9. PubMed ID: 17303569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.
    Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T
    Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway.
    Ho FM; Lin WW; Chen BC; Chao CM; Yang CR; Lin LY; Lai CC; Liu SH; Liau CS
    Cell Signal; 2006 Mar; 18(3):391-9. PubMed ID: 15970429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation.
    Kwak HJ; Park MJ; Park CM; Moon SI; Yoo DH; Lee HC; Lee SH; Kim MS; Lee HW; Shin WS; Park IC; Rhee CH; Hong SI
    Int J Cancer; 2006 Jun; 118(11):2711-20. PubMed ID: 16388516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways.
    Pan C; Lou L; Huo Y; Singh G; Chen M; Zhang D; Wu A; Zhao M; Wang S; Li J
    Ther Adv Cardiovasc Dis; 2011 Apr; 5(2):99-111. PubMed ID: 21282198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.
    Miura S; Matsuo Y; Saku K
    Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VEGFR-1 mediates endothelial differentiation and formation of blood vessels in a murine model of infantile hemangioma.
    Boscolo E; Mulliken JB; Bischoff J
    Am J Pathol; 2011 Nov; 179(5):2266-77. PubMed ID: 21945324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J; Ding M; Yang L; Liu LZ; Jiang BH
    Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High D-glucose alters PI3K and Akt signaling and leads to endothelial cell migration, proliferation and angiogenesis dysfunction].
    Yu P; Yu DM; Qi JC; Wang J; Zhang QM; Zhang JY; Tang YZ; Xing QL; Li MZ
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3425-30. PubMed ID: 17313857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
    Urbich C; Reissner A; Chavakis E; Dernbach E; Haendeler J; Fleming I; Zeiher AM; Kaszkin M; Dimmeler S
    FASEB J; 2002 May; 16(7):706-8. PubMed ID: 11978735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-arginine attenuates high glucose-accelerated senescence in human umbilical vein endothelial cells.
    Zhong W; Zou G; Gu J; Zhang J
    Diabetes Res Clin Pract; 2010 Jul; 89(1):38-45. PubMed ID: 20398956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effects of crocetin on high glucose-induced apoptosis in cultured human umbilical vein endothelial cells and its mechanism.
    Meng L; Cui L
    Arch Pharm Res; 2008 Mar; 31(3):357-63. PubMed ID: 18409050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxycycline-mediated inhibition of corneal angiogenesis: an MMP-independent mechanism.
    Su W; Li Z; Li F; Chen X; Wan Q; Liang D
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):783-8. PubMed ID: 23249709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymosin β4 reduces senescence of endothelial progenitor cells via the PI3K/Akt/eNOS signal transduction pathway.
    Li J; Yu L; Zhao Y; Fu G; Zhou B
    Mol Med Rep; 2013 Feb; 7(2):598-602. PubMed ID: 23151623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.
    Abid MR; Guo S; Minami T; Spokes KC; Ueki K; Skurk C; Walsh K; Aird WC
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):294-300. PubMed ID: 14656735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marine cyclotripeptide X-13 promotes angiogenesis in zebrafish and human endothelial cells via PI3K/Akt/eNOS signaling pathways.
    Lu XL; Xu ZL; Yao XL; Su FJ; Ye CH; Li J; Lin YC; Wang GL; Zeng JS; Huang RX; Ou JS; Sun HS; Wang LP; Pang JY; Pei Z
    Mar Drugs; 2012 Jun; 10(6):1307-1320. PubMed ID: 22822374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells.
    Greenberger S; Boscolo E; Adini I; Mulliken JB; Bischoff J
    N Engl J Med; 2010 Mar; 362(11):1005-13. PubMed ID: 20237346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of pro-metastasis phenotypes expression in malignant pleural mesothelioma by the PI3K inhibitor LY294002 or the MEK inhibitor UO126.
    Cole GW; Alleva AM; Zuo JT; Sehgal SS; Yeow WS; Schrump DS; Nguyen DM
    Anticancer Res; 2006; 26(2A):809-21. PubMed ID: 16619474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.